ACE and chronic kidney disease: Kidney Health Australia guidelines support the detection of CKD in high-risk populations and recommend pharmacological treatment with angiotensin-converting enzyme inhibitor inhibitors (ACEI) or angiotensin receptor blockers (ARB), or statins or both statins and an ACEI or ARB to reduce CKD progression and CVD risk [5].